From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Osteoporosis/Bone Disease>
  4. Archives

Osteoporosis/Bone Disease: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 176-200 of 233 are shown

How Depression Causes a Weak Leg to Stand On

This animal study suggests that depression might be a treatable risk factor for osteoporosis.

Depression, Borderline Personality Disorder, and Osteoporosis?

Risk for bone loss is especially high in younger women with major depression and borderline personality disorder.

A New COX-2 Inhibitor Is No More Cardiotoxic Than an Older NSAID

Etoricoxib had similar rates of thrombotic cardiovascular events as diclofenac, but caused more hypertension and edema.

Rituximab for Refractory RA

A single course of this agent produced significant clinical and functional benefits, measured at 24 weeks.

CV Risk with Etoricoxib vs. Diclofenac

Cardiovascular outcomes with the traditional NSAID diclofenac and the still-unapproved selective COX-2 inhibitor etoricoxib were compared by researchers who pooled results from three non–placebo-controlled randomized trials.

Adverse Events and Intravenous Immunoglobulin

Delayed adverse events occur frequently after IVIG in children.

Is Ibuprofen Helpful After Hip Replacement Surgery?

Although ibuprofen decreased the risk for ectopic bone formation, it had no effect on long-term pain or disability in this randomized, controlled study.

Chaperonin 10: Early Evidence of Efficacy in Rheumatoid Arthritis

This new therapeutic approach might offer relief for patients with treatment-resistant RA.

Bisphosphonate Is Best to Prevent Corticosteroid-Induced Osteoporosis

For patients taking corticosteroids, alendronate is more effective than alfacalcidol at preserving bone mineral density.

When Are Two Genetic Hits Enough to Break a Bone?

When double hits in the <$EMPH_O>NF1<$EMPH_C> gene lead to pseudarthrosis

Bisphosphonates and Osteonecrosis of the Jaw

ONJ is a rare but serious adverse event associated with bisphosphonate therapy.

Serious Infections with Anti-TNF Drugs for RA

The overall rate of serious infections was the same with anti-TNF drugs as with traditional DMARDs, but skin and soft-tissue infections were more common.

Infliximab (Remicade)

An overview of indications, pharmacology, dosing, and side effects, with an emphasis on what we know about its use in children

Staying in the Game: Risk Factors for Arm Injuries in Adolescent Baseball Pitchers

Pitching habits differ between those with and without arm injuries.

Trying to Define Osteonecrosis Risk Factors in HIV Patients

Prior AIDS-defining illness, lower CD4-cell–count nadir, and combination antiretroviral therapy were all associated with increased risk for osteonecrosis. However, nearly 90% of patients with this condition also had at least one traditional risk factor for it.

New Therapy for Neonatal-Onset Multisystem Inflammatory Disease

A rare condition with prominent cutaneous features responded immediately to treatment with an interleukin-1-receptor antagonist.

Osteonecrosis in HIV: Traditional Risk Factors Usually Present

In this retrospective case series, most HIV-infected patients with osteonecrosis had at least one well-recognized risk factor for the condition.

Acute Lymphocytic Leukemia or Juvenile Rheumatoid Arthritis?

Predictive factors at initial presentation could help distinguish ALL from JRA.

Is Acupuncture Effective for Knee Osteoarthritis?

Both traditional and sham needling led to less pain and better function.

Risk for Fractures with Antiepileptic Drugs

Is the risk from only enzyme-inducing AEDs?

Anti-TNF Antibody Therapies — How Safe?

Treatment of rheumatoid arthritis with anti-TNF antibodies comes with increased risk for malignancies and serious infections.

Outcomes with Raloxifene in Women with Above-Average Coronary Risk

Raloxifene use reduces risk for breast cancer but introduces other potentially serious health concerns.

Progestogen-Only Contraception: Unlimited Use Remains Appropriate

Bone-mineral density was lower in progestogen users than in nonusers, but the clinical significance of this finding isn’t clear.

Necrotizing Soft Tissue Infections: Difficult to Diagnose in Immunocompromised Patients

The disorder may present differently in immunocompromised children.

Osteomyelitis Treatment Gets Complicated

Young age and low income are associated with increased risk for catheter-associated complications.

Items 176-200 of 233 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.